Skip to product information
1 of 1

Shulph Ink

YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical Therapeutic Target

YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical Therapeutic Target

Regular price £121.50 GBP
Regular price £135.00 GBP Sale price £121.50 GBP
Sale Sold out
Tax included. Shipping calculated at checkout.
  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical Therapeutic Target

YY1 is a critical therapeutic target that is overexpressed in the majority of cancers and regulates key features of human cancers. It plays a role in tumor cell resistance to chemo and immunotherapies, making it an important area of research for cancer researchers and oncologists.

Format: Hardback
Length: 360 pages
Publication date: 20 October 2020
Publisher: Elsevier Science Publishing Co Inc


YY1 is a crucial transcription factor that plays a pivotal role in the control of cancer pathogenesis and drug resistance. It is overexpressed in the majority of cancer cases, making it a central factor in regulating the major features and characteristics of human cancers. This comprehensive book delves into the biochemical, molecular, and genetic mechanisms underlying YY1's pro-cancerous activities. It also highlights the role of YY1 in regulating tumor cell resistance to conventional chemotherapy and immunotherapies, emphasizing the importance of inhibiting YY1 in cancer treatment.

For cancer researchers, oncologists, and medical professionals seeking to understand the role of YY1 in cancer better, this book is a valuable resource. It provides a comprehensive overview of the latest research and developments in the field, helping to advance our understanding of cancer biology and potential therapeutic targets.

In conclusion, YY1 is a highly significant transcription factor that warrants further investigation and targeted therapy in cancer. This book serves as a valuable resource for researchers, oncologists, and medical professionals seeking to better understand the role of YY1 in cancer pathogenesis and develop effective treatments.

Weight: 900g
Dimension: 140 x 209 x 17 (mm)
ISBN-13: 9780128219096

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Canada, France, Ireland, Italy, Germany, Spain, Netherlands, New Zealand and the United States of America.

  • Delivery times: within 5 - 20 business days when ordering to France, Germany, Ireland, Spain, Canada and the United States. Up to 30 business days for Australia and New Zealand.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for international orders.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details